Outcomes of coronary revascularization in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review
IntroductionA growing amount of evidence suggests that metabolic dysfunction-associated steatotic liver disease (MASLD) may independently increase the risk of coronary artery disease and acute coronary syndrome, thus necessitating revascularization interventions such as percutaneous coronary interve...
Saved in:
| Main Authors: | Jacob J. Gries, Hafeez Ul Hassan Virk, Zhen Wang, Mahboob Alam, Samin Sharma, Markus Strauss, Chayakrit Krittanawong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1609071/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
by: Bruno Basil, et al.
Published: (2024-12-01) -
Dietary characteristics associated with the risk of non‐alcoholic fatty liver disease and metabolic dysfunction‐associated steatotic liver disease in non‐obese Japanese participants: A cross‐sectional study
by: Hirokazu Taniguchi, et al.
Published: (2024-05-01) -
Unmet needs of metabolic dysfunction – Associated “fatty or steatotic” liver disease
by: Yu-Ming Cheng, et al.
Published: (2025-04-01) -
Contemporary burden of mortality from chronic liver disease by sex and race/ethnicity in the United States
by: Donghee Kim, et al.
Published: (2025-07-01) -
Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease
by: Hongze Chen, et al.
Published: (2025-03-01)